Request Trial
shutterstock_684671557_nespix
NESPIX / Shutterstock.com
4 July 2023

Lewis Silkin acquires tech and life sciences firm

Lewis Silkin has integrated MSK into its practice to better manage complex portfolios across various tech sectors.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Pharma
Dr Reddy’s eyes appeal stakes as Boehringer hearing ends
22 October 2026   Questions over what Boehringer’s patents actually proved dominated the final day of the hearing, but a push for a further finding raised the stakes, with a possible appeal threatening to keep Dr Reddy’s off the market even if it won.
Pharma
Amarin and Hikma call time on six-year skinny label fight
22 October 2026   Following a major US Supreme Court win for generics, the landmark dispute has finally come to an end. A new filing brings closure to a case that raised questions over skinny labelling and induced patent infringement.
In-house counsel
WATCH: Medmix global IP head on building business-focused IP teams
21 October 2026   From building IP teams that are business orientated to tackling M&A challenges, the global head of IP management at Medmix Group—a manufacturer of high-precision delivery, mixing and application devices—explains why close collaboration, trusted external counsel and thorough due diligence matter.


Editor's picks

WATCH: Medmix global IP head on building business-focused IP teams
In-house counsel
WATCH: Medmix global IP head on building business-focused IP teams
21 October 2026

Editor's picks

In-house counsel
WATCH: Medmix global IP head on building business-focused IP teams
21 October 2026
MedTech
Boston Scientific expands dispute with J&J unit over cardiac-access technology
12 October 2026
Pharma
Dr Reddy’s v Boehringer: Data gaps take centre stage in courtroom
6 October 2026
In-house counsel
WATCH: Genevant IP director on tackling UPC-EPO opposition divide
1 October 2026
Pharma
Lilly loses Fed Circ rehearing bid, sparking enablement questions
1 October 2026
Pharma
Takeda sees off UK challenge to Elvanse SPC
28 September 2026

More features

Dr Reddy’s eyes appeal stakes as Boehringer hearing ends
Amarin and Hikma call time on six-year skinny label fight
WATCH: Medmix global IP head on building business-focused IP teams
Fish & Richardson hires duo with ‘sophisticated’ tech patent expertise
Fed Circ refuses to rehear Insulet’s $59.4m trade secret loss
Boehringer accuses Dr Reddy’s of ‘weaponising’ plausibility
Align Technology notches another win in escalating clear aligner feud
Guardant loses second patent challenge to TwinStrand amid $245m damages fallout